Related references
Note: Only part of the references are listed.The Immune Response to Tumors as a Tool toward Immunotherapy
F. Pandolfi et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The effects of trastuzumab on the CD4+CD25+FoxP3+and CD4+IL17A+T-cell axis in patients with breast cancer
C. Horlock et al.
BRITISH JOURNAL OF CANCER (2009)
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast
E. A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2009)
FOXP3 Expression and Overall Survival in Breast Cancer
Andrea Merlo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
B. S. Nedergaard et al.
BRITISH JOURNAL OF CANCER (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy
RM Caprioli
CANCER RESEARCH (2005)
CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction
P Trzonkowski et al.
CLINICAL IMMUNOLOGY (2004)
CD25+CD4+T cells contribute to the control of memory CD8+T cells
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
